Sagimet Biosciences Inc. (SGMT)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Key ratios (FY2025)
-45.8%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | — | — | $2.00M | — | — |
| Operating Income | -$56.89M | -$54.45M | -$30.74M | -$31.05M | — |
| Net Income | -$51.04M | -$45.57M | -$27.88M | -$30.50M | — |
| EPS (Diluted) | $-1.58 | $-1.45 | $-2.66 | $-165.20 | — |
| Total Assets | $116.48M | $160.26M | $96.72M | $33.03M | — |
| Total Liabilities | — | — | $5.65M | $5.36M | — |
| Shareholders' Equity | $111.38M | $155.81M | $91.06M | -$186.95M | -$158.26M |
| Cash & Equivalents | $35.02M | $75.84M | $75.14M | $158.0K | — |
| Operating Cash Flow | -$45.65M | -$42.44M | -$23.77M | -$24.49M | — |
| Shares Outstanding | 32.35M | 31.35M | 10.46M | 184.6K | — |